Viewing Study NCT01613261

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 12:53 PM
Ignite Modification Date: 2026-02-02 @ 4:19 PM
Study NCT ID: NCT01613261
Status: WITHDRAWN
Last Update Posted: 2013-11-01
First Post: 2012-06-01
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Study of TAK-733 in Combination With Alisertib in Adult Patients With Advanced Nonhematologic Malignancies
Sponsor: Millennium Pharmaceuticals, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Nonhematologic Malignancies View
Keywords:

Keywords

Keyword Brief Keyword Text View
None TAK-733, View
None alisertib, View
None MLN8237, View
None Oral MEK Inhibitor, View
None Oral Aurora A Kinase Inhibitor View